Not applicableStudy completedNCT05153135
What this trial is testing
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 4,320